Serum levels of prolactin in basal conditions and after administration of 2-bromo-5alpha-ergocryptine in normal and galactorrheic subjects.
D000236:Adenoma / Q000150:complications; D000328:Adult; D000568:Amenorrhea / Q000097:blood; D000858:Anovulation / Q000097:blood; D001971:Bromocriptine / Q000494:pharmacology*; D005260:Female; D005687:Galactorrhea / Q000097:blood*; D006801:Humans; D007775:Lactation Disorders / Q000097:blood*; D008297:Male; D010911:Pituitary Neoplasms / Q000150:complications; D011247:Pregnancy; D011388:Prolactin / Q000097:blood*
D001971:Bromocriptine; D011388:Prolactin